For the year ending 2025-12-31, SSKN has $30,521K in assets. $27,613K in debts. $7,912K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 7,912 | |||
| Restricted cash | 0 | |||
| Accounts receivable, net of allowance for credit losses of 551 and 433 at december 31, 2025 and 2024, respectively | 4,121 | |||
| Inventories | 2,814 | |||
| Prepaid expenses and other current assets | 753 | |||
| Total current assets | 15,600 | |||
| Property and equipment, gross | 37,531 | |||
| Less accumulated depreciation and amortization | 28,567 | |||
| Property and equipment, net | 8,964 | |||
| Operating lease right-of-use assets | 920 | |||
| Intangible assets, net | 3,377 | |||
| Goodwill | 1,429 | |||
| Other assets | 231 | |||
| Total assets | 30,521 | |||
| Current portion of long-term debt | 15,349 | |||
| Accounts payable | 2,758 | |||
| Accrued expenses and other current liabilities | 6,155 | |||
| Deferred revenues | 2,248 | |||
| Current portion of operating lease liabilities | 231 | |||
| Current portion of contingent consideration | 0 | |||
| Total current liabilities | 26,741 | |||
| Long-term debt, net | 0 | |||
| Deferred revenues and other liabilities | 184 | |||
| Operating lease liabilities, net of current portion | 688 | |||
| Contingent consideration, net of current portion | 0 | |||
| Total liabilities | 27,613 | |||
| Series c convertible preferred stock, 0.10 par value 10,000,000 shares authorized, no shares issued and outstanding | 0 | |||
| Common stock, 0.001 par value 150,000,000 shares authorized 5,888,199 and 4,171,161 shares issued and outstanding at december 31, 2025 and 2024, respectively | 6 | |||
| Additional paid-in capital | 257,307 | |||
| Accumulated deficit | -254,405 | |||
| Total stockholders equity | 2,908 | |||
| Total liabilities and stockholders equity | 30,521 | |||
STRATA Skin Sciences, Inc. (SSKN)
STRATA Skin Sciences, Inc. (SSKN)